SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus
Patrick C. Y. Woo(National Chung Hsing University), Kwok‐Yung Yuen(University of Hong Kong - Shenzhen Hospital), Beatrice H. L. Wong(Queen Mary Hospital), Susanna K. P. Lau(University of Hong Kong), Lei-po Wong(Queen Mary Hospital), David D. Ho(Columbia University), Wei He(Lishui University), Zhiwei Chen(Fujian Medical University), Chi Ma(Macau University of Science and Technology), Kwok‐Hung Chan(University of Hong Kong), Jim K.H. Chan(Queen Mary Hospital), Hoi-Wah Tsoi(Chinese University of Hong Kong), Linqi Zhang(Hebei University of Chinese Medicine)
Cited by 59
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k